Choosing a DTC Advertising Agency for a Pharma Brand
How pharma brands choose a DTC advertising agency: capabilities to require, questions to ask, a scorecard, and red flags in pitches.
The short answer
A good DTC advertising agency for a pharma brand combines creative that works within FDA rules, media planning across TV, CTV, digital, and social, privacy-safe audience and data practices, and outcome measurement tied to patient starts. When choosing, ask for work examples with the regulatory context explained, the team who will actually work on the business, their review process, how they measure outcomes, and how they handle conflicts with competing brands.
DTC agencies vary widely. Some are strong creative shops with limited media depth. Others are media-led with limited creative. Some have deep pharma experience; others are consumer agencies adding health. Knowing what you need narrows the field.
Capabilities to require
| Capability | What good looks like |
|---|---|
| Regulated creative | Ideas that work within fair balance and label limits from the start |
| Media planning | TV, CTV, digital, social, search, with deduplicated reach planning |
| Audience and data | Privacy-reviewed targeting, clear data sourcing |
| Measurement | Outcome studies with control groups, not just engagement |
| Social and community | Moderation and adverse event processes |
| Review workflow | Efficient MLR submissions, version control |
Questions to ask
- Show us DTC work and explain the regulatory constraints you worked within.
- Who will be on our account day to day, and what is their pharma experience?
- How do you prepare materials for MLR review, and what is your typical number of review rounds?
- How do you plan and measure reach and frequency across TV and CTV?
- How do you measure patient outcomes? Show a study with methods.
- What is your process for privacy review of audiences and website tracking?
- How do you handle adverse events found in social comments?
- What competing brands do you work on, and how are conflicts managed?
- How are you paid, and do you receive any income from media or data partners?
Red flags
- Case studies with outcome claims but no methods.
- Click and engagement metrics as the main proof of success.
- Senior people in the pitch who will not work on the business.
- Vague answers about data sources for audiences.
- Unwillingness to discuss compensation and partner income. See agency compensation and incentives.
Running the selection
- Write a brief with the brand's objective, audience, and constraints.
- Shortlist three or four agencies.
- Ask each for a short response to a real problem, not a full speculative campaign.
- Meet the proposed team.
- Check references from other pharma clients.
- Score on a weighted scorecard.
A scorecard
| Area | Weight |
|---|---|
| Regulated creative | 25% |
| Media and measurement | 25% |
| Team and experience | 20% |
| Privacy and compliance processes | 15% |
| Commercial terms and transparency | 15% |
Common mistakes
- Choosing on the creative pitch alone.
- Not meeting the working team.
- Ignoring how the agency measures outcomes.
- Skipping the conflicts question.
Practical takeaway
Ask every finalist to walk through one past DTC campaign from brief to outcome study, including what review changed and what the outcome data showed. How candidly they discuss the parts that went wrong is often the best signal of how they will work with you.
Frequently asked questions
What should a pharma DTC agency do?
Strategy, creative, and often media planning and buying for patient-facing campaigns, within FDA promotion rules, plus measurement of outcomes.
Should DTC and HCP be with the same agency?
It depends on scale, integration needs, and agency strengths. See the article on one agency vs. two in this library.
What are red flags in a DTC agency pitch?
Work shown without regulatory context, measurement based on clicks, vague answers on privacy, and a pitch team that will not work on the account.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.